Standard BioTools's total assets for Q2 2026 were $627.22M, a decrease of -1.86% from the previous quarter. CH:FLB total liabilities were $87.25M for the fiscal quarter, a 11.87% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.